Literature DB >> 33779652

Cardiac MRI and FDG PET in Cardiac Sarcoidosis: Competitors or Collaborators?

Matthias Gutberlet1.   

Abstract

Entities:  

Year:  2020        PMID： 33779652      PMCID： PMC7977942          DOI： 10.1148/ryct.2020200347

Source DB:  PubMed          Journal:  Radiol Cardiothorac Imaging        ISSN： 2638-6135


× No keyword cloud information.
  9 in total

1.  Prognostic value of cardiovascular magnetic resonance in patients with biopsy-proven systemic sarcoidosis.

Authors:  Louis Flamée; Rolf Symons; Ganna Degtiarova; Tom Dresselaers; Olivier Gheysens; Wim Wuyts; Johan Van Cleemput; Jan Bogaert
Journal:  Eur Radiol       Date:  2020-03-12       Impact factor: 5.315

2.  Comprehensive Cardiac Magnetic Resonance Imaging in Patients With Suspected Myocarditis: The MyoRacer-Trial.

Authors:  Philipp Lurz; Christian Luecke; Ingo Eitel; Felix Föhrenbach; Clara Frank; Matthias Grothoff; Suzanne de Waha; Karl-Philipp Rommel; Julia Anna Lurz; Karin Klingel; Reinhard Kandolf; Gerhard Schuler; Holger Thiele; Matthias Gutberlet
Journal:  J Am Coll Cardiol       Date:  2016-04-19       Impact factor: 24.094

Review 3.  The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience.

Authors:  George Youssef; Eugene Leung; Ilias Mylonas; Pablo Nery; Kathryn Williams; Gerald Wisenberg; Karen Y Gulenchyn; Robert A Dekemp; Jean Dasilva; David Birnie; George A Wells; Rob S B Beanlands
Journal:  J Nucl Med       Date:  2012-01-06       Impact factor: 10.057

4.  Initial Experience With Simultaneous 18F-FDG PET/MRI in the Evaluation of Cardiac Sarcoidosis and Myocarditis.

Authors:  Kate Hanneman; Michael Kadoch; Henry H Guo; Mehran Jamali; Andrew Quon; Andrei Iagaru; Robert Herfkens
Journal:  Clin Nucl Med       Date:  2017-07       Impact factor: 7.794

5.  Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis.

Authors:  Eleanor C Wicks; Leon J Menezes; Anna Barnes; Saidi A Mohiddin; Neha Sekhri; Joanna C Porter; Helen L Booth; Emily Garrett; Riyaz S Patel; Menelaos Pavlou; Ashley M Groves; Perry M Elliott
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2018-07-01       Impact factor: 6.875

6.  Comparison of volumetric and functional parameters in simultaneous cardiac PET/MR: feasibility of volumetric assessment with residual activity from prior PET/CT.

Authors:  C Lücke; B Oppolzer; P Werner; B Foldyna; P Lurz; T Jochimsen; B Brenneis; L Lehmkuhl; B Sattler; M Grothoff; H Barthel; O Sabri; M Gutberlet
Journal:  Eur Radiol       Date:  2017-06-19       Impact factor: 5.315

7.  Acute adverse events in cardiac MR imaging with gadolinium-based contrast agents: results from the European Society of Cardiovascular Radiology (ESCR) MRCT Registry in 72,839 patients.

Authors:  Johannes Uhlig; Christian Lücke; Rozemarijn Vliegenthart; Christian Loewe; Matthias Grothoff; Andreas Schuster; Philipp Lurz; Alexis Jacquier; Marco Francone; Antonia Zapf; Christoph Schülke; Matthias Stefan May; Jens Bremerich; Joachim Lotz; Matthias Gutberlet
Journal:  Eur Radiol       Date:  2019-04-30       Impact factor: 5.315

Review 8.  Hybrid cardiac imaging using PET/MRI: a joint position statement by the European Society of Cardiovascular Radiology (ESCR) and the European Association of Nuclear Medicine (EANM).

Authors:  Felix Nensa; Fabian Bamberg; Christoph Rischpler; Leon Menezes; Thorsten D Poeppel; Christian la Fougère; Dietrich Beitzke; Sazan Rasul; Christian Loewe; Konstantin Nikolaou; Jan Bucerius; Andreas Kjaer; Matthias Gutberlet; Niek H Prakken; Rozemarijn Vliegenthart; Riemer H J A Slart; Stephan G Nekolla; Martin L Lassen; Bernd J Pichler; Thomas Schlosser; Alexis Jacquier; Harald H Quick; Michael Schäfers; Marcus Hacker
Journal:  Eur Radiol       Date:  2018-05-02       Impact factor: 5.315

9.  Same day comparison of PET/CT and PET/MR in patients with cardiac sarcoidosis.

Authors:  G Wisenberg; J D Thiessen; W Pavlovsky; J Butler; B Wilk; F S Prato
Journal:  J Nucl Cardiol       Date:  2019-01-02       Impact factor: 5.952
  9 in total
  1 in total

1.  Combined simultaneous FDG-PET/MRI with T1 and T2 mapping as an imaging biomarker for the diagnosis and prognosis of suspected cardiac sarcoidosis.

Authors:  Edward Cheung; Sarah Ahmad; Matthew Aitken; Rosanna Chan; Robert M Iwanochko; Meyer Balter; Ur Metser; Patrick Veit-Haibach; Filio Billia; Yasbanoo Moayedi; Heather J Ross; Kate Hanneman
Journal:  Eur J Hybrid Imaging       Date:  2021-12-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.